Description
DICLOFENAC (MONOFLAM) SUSP 60ML is a non-steroidal anti-inflammatory drug (NSAID) in oral suspension form, containing diclofenac sodium as the active ingredient. It is specially formulated for patients who have difficulty swallowing tablets or require flexible dosing, such as children or elderly patients. This suspension provides effective relief from pain and inflammation associated with various conditions.
Active Ingredient:
-
Diclofenac Sodium (concentration per ml as per formulation)
Indications:
-
Relief of pain and inflammation in musculoskeletal disorders such as arthritis, tendonitis, and bursitis
-
Management of acute soft tissue injuries like sprains and strains
-
Treatment of fever and mild to moderate pain due to other causes
-
Suitable for pediatric and geriatric patients who need NSAID therapy
Mechanism of Action:
Diclofenac works by inhibiting the cyclooxygenase (COX-1 and COX-2) enzymes, leading to a decreased synthesis of prostaglandins, which are responsible for causing pain, inflammation, and fever. The suspension form allows for rapid absorption and onset of action.
Dosage and Administration:
-
Dosage varies based on age, weight, and severity of symptoms; follow the prescribing physician’s instructions carefully
-
Shake well before use
-
Measure dose accurately using a measuring spoon or cup
-
Administer with or after food to reduce gastrointestinal discomfort
Precautions:
-
Not recommended for patients with active gastrointestinal bleeding or ulcers
-
Use with caution in patients with kidney, liver, or cardiovascular conditions
-
Avoid use during the third trimester of pregnancy
-
Monitor for signs of allergic reactions or side effects
Side Effects:
-
Possible gastrointestinal upset such as nausea or abdominal pain
-
Rare skin reactions or allergic responses
-
Headache or dizziness in some cases
MONOFLAM Suspension 60ml offers an easy-to-administer and effective option for managing pain and inflammation, especially in patients requiring liquid medication.
Reviews
There are no reviews yet.